COA Library
Quality Documentation
COA Library
Independent third-party lab verification for every compound. Select a product to view its Certificate of Analysis.
67
Total COAs
32
Compounds
98%+
Min Purity
BTLabs
Testing Lab
Fat Loss
Fat Loss2 COAs
Adipotide
Targeted Adipose Reduction · 2mg, 5mg
→
Fat Loss2 COAs
CAG-8
Amylin Receptor Fat Loss · 5mg, 10mg
→
Fat Loss1 COA
CS-Dual
Dual Fat Loss Stack · 10mg
→
Fat Loss1 COA
LB-LC
Lipolytic Injection Blend · 10mg
→
Fat Loss1 COA
LC526
Lipotropic Fat Burner · 10ml
→
Fat Loss8 COAs
R-943
Triple Agonist · GLP-1/GIP/Glucagon · 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg
→
Fat Loss5 COAs
SG-417
GLP-1 Fat Loss Compound · 5mg, 10mg, 15mg, 20mg, 30mg
→
Fat Loss1 COA
SV-906
GLP-1/Glucagon Dual Agonist · 10mg
→
Fat Loss8 COAs
TZ-329
GLP-1/GIP Dual Agonist · 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg
→
Muscle & Recovery
Muscle & Recovery1 COA
KPV
Anti-Inflammatory Tripeptide · 10mg
→
Muscle & Recovery1 COA
LL37
Antimicrobial & Immune · 5mg
→
Muscle & Recovery1 COA
SLU-PP-332
Exercise Mimetic · 5mg
→
Muscle & Recovery3 COAs
Sermorelin
Physiological GH Stimulation · 2mg, 5mg, 10mg
→
Muscle & Recovery2 COAs
T-RH
GH Release & Visceral Fat · 2mg, 10mg
→
Muscle & Recovery3 COAs
TB500
Systemic Recovery & Healing · 2mg, 5mg, 10mg
→
Muscle & Recovery1 COA
Thymalin
Thymic Immune Peptide · 10mg
→
Sexual Health
Sexual Health2 COAs
CGP
LH Mimic / Testosterone · 5000iu, 10000iu
→
Sexual Health1 COA
MT-I
Melanocortin / Tanning · 10mg
→
Sexual Health1 COA
MT-II
Sexual Health & Tanning · 10mg
→
Sexual Health3 COAs
Oxytocin
Bonding Neuropeptide · 2mg, 5mg, 10mg
→
Sexual Health1 COA
PT-141
Sexual Arousal Peptide · 10mg
→
Cognitive
Cognitive2 COAs
DSIP
Delta Sleep-Inducing Peptide · 5mg, 10mg
→
Cognitive2 COAs
Epithalon
Telomerase / Longevity · 10mg, 50mg
→
Cognitive1 COA
Pinealon
Neuroprotection & Cognition · 20mg
→
Cognitive2 COAs
Selank
Anxiolytic & Cognitive Support · 5mg, 10mg
→
Cognitive2 COAs
Semax
Nootropic & Neuroprotection · 5mg, 11mg
→
General Health
General Health2 COAs
GHK-Cu
Copper Peptide — Skin & Healing · 10mg, 100mg
→
General Health1 COA
Melatonin
Circadian & Antioxidant · 10mg
→
General Health2 COAs
SS-31
Mitochondria-Targeted · 10mg, 50mg
→
Other
Other2 COAs
5-Amino-1MQ
NNMT Inhibitor / Fat Loss · 5mg, 50mg
→
Other1 COA
Gonadorelin
Synthetic GnRH Analogue · 2mg
→
Other1 COA
L-Carnitine
Mitochondrial Fat Transport · 10ml
→
🔬 More COAs added with every new batch
All compounds tested by independent analytical laboratories.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-145-18
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/12/2025
Date Tested:11/12/2025
Customer:PEPTOVA
Testing material:5-Amino-1MQ
Lot Number:PU5Q92F
BT Sample ID:005000038801015
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and green cap
Labeled as:5-Amino-1MQ
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
5-Amino-1MQ
5mg
5-Amino-1MQ
5mg
Lot: PU5Q92F
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 29.4 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.8 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.45 mg (108.9 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-146-14
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/27/2025
Date Tested:11/27/2025
Customer:PEPTOVA
Testing material:5-Amino-1MQ
Lot Number:XS7NKSX
BT Sample ID:005000038801022
Labeled Peptide:—
Content/Potency:50mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and teal cap
Labeled as:5-Amino-1MQ
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
5-Amino-1MQ
50mg
5-Amino-1MQ
50mg
Lot: XS7NKSX
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 202 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.4 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 50 mg | 50.75 mg (101.5 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-128-88
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/08/2025
Date Tested:12/08/2025
Customer:PEPTOVA
Testing material:Adipotide (FTPP)
Lot Number:Z050RQ9
BT Sample ID:005000038800896
Labeled Peptide:—
Content/Potency:2mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and green cap
Labeled as:Adipotide (FTPP)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Adipotide
2mg
Adipotide
2mg
Lot: Z050RQ9
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 11.5 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.6 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 2 mg | 2.07 mg (103.5 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-129-91
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:03/04/2026
Date Tested:03/04/2026
Customer:PEPTOVA
Testing material:Adipotide (FTPP)
Lot Number:4X0XWHG
BT Sample ID:005000038800903
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and purple cap
Labeled as:Adipotide (FTPP)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Adipotide
5mg
Adipotide
5mg
Lot: 4X0XWHG
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 26.3 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.0 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.22 mg (104.5 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 March 2026
Rev 1.0 March 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-126-28
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/03/2026
Date Tested:02/03/2026
Customer:PEPTOVA
Testing material:Cagrilintide (CAG-8)
Lot Number:D212P6R
BT Sample ID:005000038800882
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and teal cap
Labeled as:Cagrilintide (CAG-8)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Cagrilintide
5mg
Cagrilintide
5mg
Lot: D212P6R
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 26.2 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.0 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.42 mg (108.4 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-127-82
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/24/2026
Date Tested:02/24/2026
Customer:PEPTOVA
Testing material:Cagrilintide (CAG-8)
Lot Number:DLX09Q9
BT Sample ID:005000038800889
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and green cap
Labeled as:Cagrilintide (CAG-8)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Cagrilintide
10mg
Cagrilintide
10mg
Lot: DLX09Q9
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 51.5 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.0 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.6 mg (106 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-142-12
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:01/05/2026
Date Tested:01/05/2026
Customer:PEPTOVA
Testing material:CGP (Chorionic Gonadotropin)
Lot Number:7EZCTCV
BT Sample ID:005000038800994
Labeled Peptide:—
Content/Potency:5000 IU
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and clear cap
Labeled as:CGP (Chorionic Gonadotropin)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
CGP
5000 IU
CGP
5000 IU
Lot: 7EZCTCV
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White to off-white powder | White powder |
| Mass | USP <41> | As recorded | 66.2 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Confirms glycoprotein via characteristic bands | CONFORMS |
| HPLC Purity Assay | USP <621> | Specifications: ≥ 98 % | 99.2 % |
| Biological Activity | In-house | ≥ 95% of labeled IU | CONFORMS |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 January 2026
Rev 1.0 January 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-143-14
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/22/2025
Date Tested:12/22/2025
Customer:PEPTOVA
Testing material:CGP (Chorionic Gonadotropin)
Lot Number:PGKWHYP
BT Sample ID:005000038801001
Labeled Peptide:—
Content/Potency:10000 IU
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and yellow cap
Labeled as:CGP (Chorionic Gonadotropin)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
CGP
10000 IU
CGP
10000 IU
Lot: PGKWHYP
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White to off-white powder | White powder |
| Mass | USP <41> | As recorded | 54.5 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Confirms glycoprotein via characteristic bands | CONFORMS |
| HPLC Purity Assay | USP <621> | Specifications: ≥ 98 % | 99.4 % |
| Biological Activity | In-house | ≥ 95% of labeled IU | CONFORMS |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-125-19
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:03/04/2026
Date Tested:03/04/2026
Customer:PEPTOVA
Testing material:CagriSema (CS-Dual)
Lot Number:CXAVY74
BT Sample ID:005000038800875
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and red cap
Labeled as:CagriSema (CS-Dual)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
CagriSema
10mg
CagriSema
10mg
Lot: CXAVY74
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 49.4 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.0 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.74 mg (107.4 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 March 2026
Rev 1.0 March 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-166-96
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/11/2026
Date Tested:02/11/2026
Customer:PEPTOVA
Testing material:DSIP (Delta Sleep Inducing Peptide)
Lot Number:ZJK81QK
BT Sample ID:005000038801162
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and clear cap
Labeled as:DSIP (Delta Sleep Inducing Peptide)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
DSIP
5mg
DSIP
5mg
Lot: ZJK81QK
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 27.9 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.5 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.47 mg (109.5 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-167-38
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:01/14/2026
Date Tested:01/14/2026
Customer:PEPTOVA
Testing material:DSIP (Delta Sleep Inducing Peptide)
Lot Number:RUPCVNX
BT Sample ID:005000038801169
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and clear cap
Labeled as:DSIP (Delta Sleep Inducing Peptide)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
DSIP
10mg
DSIP
10mg
Lot: RUPCVNX
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 49.9 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.1 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.24 mg (102.4 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 January 2026
Rev 1.0 January 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-164-90
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/22/2025
Date Tested:12/22/2025
Customer:PEPTOVA
Testing material:Epithalon
Lot Number:56HWMQX
BT Sample ID:005000038801148
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and teal cap
Labeled as:Epithalon
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Epithalon
10mg
Epithalon
10mg
Lot: 56HWMQX
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 52.6 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.8 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.58 mg (105.8 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-165-86
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/18/2026
Date Tested:02/18/2026
Customer:PEPTOVA
Testing material:Epithalon
Lot Number:7JDE10B
BT Sample ID:005000038801155
Labeled Peptide:—
Content/Potency:50mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and green cap
Labeled as:Epithalon
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Epithalon
50mg
Epithalon
50mg
Lot: 7JDE10B
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 193.6 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.4 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 50 mg | 54.55 mg (109.1 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-157-24
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/22/2025
Date Tested:12/22/2025
Customer:PEPTOVA
Testing material:GHK-Cu (Copper Peptide)
Lot Number:XSXU1S7
BT Sample ID:005000038801099
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and green cap
Labeled as:GHK-Cu (Copper Peptide)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
GHK-Cu
10mg
GHK-Cu
10mg
Lot: XSXU1S7
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 49.6 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.5 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.42 mg (104.2 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-158-78
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/24/2025
Date Tested:11/24/2025
Customer:PEPTOVA
Testing material:GHK-Cu (Copper Peptide)
Lot Number:7614VAR
BT Sample ID:005000038801106
Labeled Peptide:—
Content/Potency:100mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and teal cap
Labeled as:GHK-Cu (Copper Peptide)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
GHK-Cu
100mg
GHK-Cu
100mg
Lot: 7614VAR
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 350.4 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.5 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 100 mg | 103.1 mg (103.1 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-144-79
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/27/2025
Date Tested:11/27/2025
Customer:PEPTOVA
Testing material:Gonadorelin Acetate
Lot Number:6DUV4XA
BT Sample ID:005000038801008
Labeled Peptide:—
Content/Potency:2mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and orange cap
Labeled as:Gonadorelin Acetate
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Gonadorelin
2mg
Gonadorelin
2mg
Lot: 6DUV4XA
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 12.9 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.6 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 2 mg | 2.14 mg (107 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-141-33
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/11/2026
Date Tested:02/11/2026
Customer:PEPTOVA
Testing material:KPV (Lys-Pro-Val)
Lot Number:Y365234
BT Sample ID:005000038800987
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and red cap
Labeled as:KPV (Lys-Pro-Val)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
KPV
10mg
KPV
10mg
Lot: Y365234
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 54.5 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.5 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.4 mg (104 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-123-76
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/12/2025
Date Tested:11/12/2025
Customer:PEPTOVA
Testing material:Lipolytic Complex (LB-LC)
Lot Number:RQD2MEH
BT Sample ID:005000038800861
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and clear cap
Labeled as:Lipolytic Complex (LB-LC)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Lipolytic
10mg
Lipolytic
10mg
Lot: RQD2MEH
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 52 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.3 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.72 mg (107.2 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-124-79
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:01/05/2026
Date Tested:01/05/2026
Customer:PEPTOVA
Testing material:LC526 (Fat Blaster)
Lot Number:0PWF65W
BT Sample ID:005000038800868
Labeled Peptide:—
Content/Potency:10ml
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and orange cap
Labeled as:LC526 (Fat Blaster)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
LC526
10ml
LC526
10ml
Lot: 0PWF65W
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 48.3 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.6 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.23 mg (102.3 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 January 2026
Rev 1.0 January 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-140-64
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/22/2025
Date Tested:12/22/2025
Customer:PEPTOVA
Testing material:L-Carnitine
Lot Number:BG3Q5EZ
BT Sample ID:005000038800980
Labeled Peptide:—
Content/Potency:10ml
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and yellow cap
Labeled as:L-Carnitine
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
L-Carnitine
10ml
L-Carnitine
10ml
Lot: BG3Q5EZ
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <631> | Clear, colorless solution | Clear, colorless solution |
| pH | USP <791> | 6.0 – 7.5 | 6.7 |
| Identity (HPLC) | USP <621> | Confirms L-Carnitine | CONFORMS |
| HPLC Purity Assay | USP <621> | Specifications: ≥ 98 % | 99.0 % |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-139-20
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/02/2025
Date Tested:12/02/2025
Customer:PEPTOVA
Testing material:LL-37 (Cathelicidin)
Lot Number:VUDSPAD
BT Sample ID:005000038800973
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and green cap
Labeled as:LL-37 (Cathelicidin)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
LL-37
5mg
LL-37
5mg
Lot: VUDSPAD
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 26.8 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.1 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.04 mg (100.9 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-135-15
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:01/14/2026
Date Tested:01/14/2026
Customer:PEPTOVA
Testing material:MT-I (Melanotan I)
Lot Number:83JMUFJ
BT Sample ID:005000038800945
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and red cap
Labeled as:MT-I (Melanotan I)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
MT-I
10mg
MT-I
10mg
Lot: 83JMUFJ
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 49.1 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.5 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.79 mg (107.9 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 January 2026
Rev 1.0 January 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-134-52
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/03/2026
Date Tested:02/03/2026
Customer:PEPTOVA
Testing material:MT-II (Melanotan II)
Lot Number:B0TAZSZ
BT Sample ID:005000038800938
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and clear cap
Labeled as:MT-II (Melanotan II)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
MT-II
10mg
MT-II
10mg
Lot: B0TAZSZ
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 51.6 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.6 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.22 mg (102.2 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-138-69
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/24/2026
Date Tested:02/24/2026
Customer:PEPTOVA
Testing material:Melatonin
Lot Number:LHEZAHS
BT Sample ID:005000038800966
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and purple cap
Labeled as:Melatonin
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Melatonin
10mg
Melatonin
10mg
Lot: LHEZAHS
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 49.5 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.5 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.74 mg (107.4 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-131-80
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/24/2025
Date Tested:11/24/2025
Customer:PEPTOVA
Testing material:Oxytocin
Lot Number:B4TAPC1
BT Sample ID:005000038800917
Labeled Peptide:—
Content/Potency:2mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and yellow cap
Labeled as:Oxytocin
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Oxytocin
2mg
Oxytocin
2mg
Lot: B4TAPC1
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 12.2 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.7 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 2 mg | 2.16 mg (107.9 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-132-83
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/11/2026
Date Tested:02/11/2026
Customer:PEPTOVA
Testing material:Oxytocin
Lot Number:6PNHEVY
BT Sample ID:005000038800924
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and orange cap
Labeled as:Oxytocin
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Oxytocin
5mg
Oxytocin
5mg
Lot: 6PNHEVY
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 26.8 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.1 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.45 mg (108.9 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-133-21
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:03/04/2026
Date Tested:03/04/2026
Customer:PEPTOVA
Testing material:Oxytocin
Lot Number:UX8RW98
BT Sample ID:005000038800931
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and blue cap
Labeled as:Oxytocin
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Oxytocin
10mg
Oxytocin
10mg
Lot: UX8RW98
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 50.2 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.2 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.23 mg (102.3 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 March 2026
Rev 1.0 March 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-130-54
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/18/2026
Date Tested:02/18/2026
Customer:PEPTOVA
Testing material:PT-141 (Bremelanotide)
Lot Number:36ZW5JX
BT Sample ID:005000038800910
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and yellow cap
Labeled as:PT-141 (Bremelanotide)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
PT-141
10mg
PT-141
10mg
Lot: 36ZW5JX
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 51 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.8 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.56 mg (105.6 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-159-49
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/22/2025
Date Tested:12/22/2025
Customer:PEPTOVA
Testing material:Pinealon
Lot Number:YF4BEKC
BT Sample ID:005000038801113
Labeled Peptide:—
Content/Potency:20mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and purple cap
Labeled as:Pinealon
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Pinealon
20mg
Pinealon
20mg
Lot: YF4BEKC
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 95.5 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.3 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 20 mg | 21.14 mg (105.7 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-115-67
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/18/2025
Date Tested:11/18/2025
Customer:PEPTOVA
Testing material:Retatrutide (R-943)
Lot Number:QHJHUH0
BT Sample ID:005000038800805
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and blue cap
Labeled as:Retatrutide (R-943)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Retatrutide
5mg
Retatrutide
5mg
Lot: QHJHUH0
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 28.1 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.3 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.24 mg (104.8 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-116-35
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:01/22/2026
Date Tested:01/22/2026
Customer:PEPTOVA
Testing material:Retatrutide (R-943)
Lot Number:LVJ5CX2
BT Sample ID:005000038800812
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and orange cap
Labeled as:Retatrutide (R-943)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Retatrutide
10mg
Retatrutide
10mg
Lot: LVJ5CX2
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 48 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.7 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.19 mg (101.9 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 January 2026
Rev 1.0 January 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-117-90
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:03/12/2026
Date Tested:03/12/2026
Customer:PEPTOVA
Testing material:Retatrutide (R-943)
Lot Number:BYF4KCX
BT Sample ID:005000038800819
Labeled Peptide:—
Content/Potency:15mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and green cap
Labeled as:Retatrutide (R-943)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Retatrutide
15mg
Retatrutide
15mg
Lot: BYF4KCX
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 73.3 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.8 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 15 mg | 15.33 mg (102.2 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 March 2026
Rev 1.0 March 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-118-34
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/27/2025
Date Tested:11/27/2025
Customer:PEPTOVA
Testing material:Retatrutide (R-943)
Lot Number:1UDWRSX
BT Sample ID:005000038800826
Labeled Peptide:—
Content/Potency:20mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and clear cap
Labeled as:Retatrutide (R-943)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Retatrutide
20mg
Retatrutide
20mg
Lot: 1UDWRSX
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 91.4 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.6 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 20 mg | 20.1 mg (100.5 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-119-33
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/18/2026
Date Tested:02/18/2026
Customer:PEPTOVA
Testing material:Retatrutide (R-943)
Lot Number:2T8Z8MS
BT Sample ID:005000038800833
Labeled Peptide:—
Content/Potency:30mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and blue cap
Labeled as:Retatrutide (R-943)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Retatrutide
30mg
Retatrutide
30mg
Lot: 2T8Z8MS
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 129.5 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.5 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 30 mg | 31.41 mg (104.7 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-120-32
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/15/2025
Date Tested:12/15/2025
Customer:PEPTOVA
Testing material:Retatrutide (R-943)
Lot Number:KU38DGM
BT Sample ID:005000038800840
Labeled Peptide:—
Content/Potency:40mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and green cap
Labeled as:Retatrutide (R-943)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Retatrutide
40mg
Retatrutide
40mg
Lot: KU38DGM
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 159.1 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.4 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 40 mg | 42.48 mg (106.2 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-121-31
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:03/12/2026
Date Tested:03/12/2026
Customer:PEPTOVA
Testing material:Retatrutide (R-943)
Lot Number:JV6MQBG
BT Sample ID:005000038800847
Labeled Peptide:—
Content/Potency:50mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and red cap
Labeled as:Retatrutide (R-943)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Retatrutide
50mg
Retatrutide
50mg
Lot: JV6MQBG
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 190.7 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.3 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 50 mg | 55.15 mg (110.3 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 March 2026
Rev 1.0 March 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-122-30
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:01/14/2026
Date Tested:01/14/2026
Customer:PEPTOVA
Testing material:Retatrutide (R-943)
Lot Number:3WBC76B
BT Sample ID:005000038800854
Labeled Peptide:—
Content/Potency:60mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and yellow cap
Labeled as:Retatrutide (R-943)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Retatrutide
60mg
Retatrutide
60mg
Lot: 3WBC76B
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 217.1 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.2 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 60 mg | 63.78 mg (106.3 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 January 2026
Rev 1.0 January 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-110-63
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/02/2025
Date Tested:12/02/2025
Customer:PEPTOVA
Testing material:Semaglutide (SG-417)
Lot Number:JV41UP0
BT Sample ID:005000038800770
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and purple cap
Labeled as:Semaglutide (SG-417)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Semaglutide
5mg
Semaglutide
5mg
Lot: JV41UP0
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 25.5 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.8 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.17 mg (103.5 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-111-99
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/03/2026
Date Tested:02/03/2026
Customer:PEPTOVA
Testing material:Semaglutide (SG-417)
Lot Number:0HE9QKW
BT Sample ID:005000038800777
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and red cap
Labeled as:Semaglutide (SG-417)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Semaglutide
10mg
Semaglutide
10mg
Lot: 0HE9QKW
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 50.2 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.8 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.83 mg (108.3 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-112-64
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/12/2025
Date Tested:11/12/2025
Customer:PEPTOVA
Testing material:Semaglutide (SG-417)
Lot Number:VEBCXW9
BT Sample ID:005000038800784
Labeled Peptide:—
Content/Potency:15mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and teal cap
Labeled as:Semaglutide (SG-417)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Semaglutide
15mg
Semaglutide
15mg
Lot: VEBCXW9
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 72.3 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.0 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 15 mg | 15.13 mg (100.9 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-113-98
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/02/2025
Date Tested:12/02/2025
Customer:PEPTOVA
Testing material:Semaglutide (SG-417)
Lot Number:3J9LDE1
BT Sample ID:005000038800791
Labeled Peptide:—
Content/Potency:20mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and yellow cap
Labeled as:Semaglutide (SG-417)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Semaglutide
20mg
Semaglutide
20mg
Lot: 3J9LDE1
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 91 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.7 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 20 mg | 21.74 mg (108.7 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-114-97
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/24/2026
Date Tested:02/24/2026
Customer:PEPTOVA
Testing material:Semaglutide (SG-417)
Lot Number:JK0V896
BT Sample ID:005000038800798
Labeled Peptide:—
Content/Potency:30mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and purple cap
Labeled as:Semaglutide (SG-417)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Semaglutide
30mg
Semaglutide
30mg
Lot: JK0V896
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 125.2 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.6 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 30 mg | 31.17 mg (103.9 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-153-56
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/27/2025
Date Tested:11/27/2025
Customer:PEPTOVA
Testing material:SLU-PP-332
Lot Number:VCX4MCX
BT Sample ID:005000038801071
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and clear cap
Labeled as:SLU-PP-332
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
SLU-PP-332
5mg
SLU-PP-332
5mg
Lot: VCX4MCX
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 28.3 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.1 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.33 mg (106.5 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-136-80
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/03/2026
Date Tested:02/03/2026
Customer:PEPTOVA
Testing material:SS-31 (Elamipretide)
Lot Number:3CRSRGP
BT Sample ID:005000038800952
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and clear cap
Labeled as:SS-31 (Elamipretide)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
SS-31
10mg
SS-31
10mg
Lot: 3CRSRGP
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 53.9 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.7 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.9 mg (109 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-137-76
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/12/2025
Date Tested:11/12/2025
Customer:PEPTOVA
Testing material:SS-31 (Elamipretide)
Lot Number:5NZAB23
BT Sample ID:005000038800959
Labeled Peptide:—
Content/Potency:50mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and yellow cap
Labeled as:SS-31 (Elamipretide)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
SS-31
50mg
SS-31
50mg
Lot: 5NZAB23
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 195 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.3 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 50 mg | 50.4 mg (100.8 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-109-97
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/22/2025
Date Tested:12/22/2025
Customer:PEPTOVA
Testing material:Survodutide (SV-906)
Lot Number:LRCHW5U
BT Sample ID:005000038800763
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and orange cap
Labeled as:Survodutide (SV-906)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Survodutide
10mg
Survodutide
10mg
Lot: LRCHW5U
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 49.6 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.6 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.62 mg (106.2 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-160-18
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/18/2025
Date Tested:11/18/2025
Customer:PEPTOVA
Testing material:Selank
Lot Number:7ATQZNH
BT Sample ID:005000038801120
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and teal cap
Labeled as:Selank
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Selank
5mg
Selank
5mg
Lot: 7ATQZNH
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 27.7 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.8 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.24 mg (104.7 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-161-22
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/08/2025
Date Tested:12/08/2025
Customer:PEPTOVA
Testing material:Selank
Lot Number:H87G7JH
BT Sample ID:005000038801127
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and green cap
Labeled as:Selank
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Selank
10mg
Selank
10mg
Lot: H87G7JH
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 51.4 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.3 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.77 mg (107.7 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-162-58
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/03/2026
Date Tested:02/03/2026
Customer:PEPTOVA
Testing material:Semax
Lot Number:VUMN9G3
BT Sample ID:005000038801134
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and yellow cap
Labeled as:Semax
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Semax
5mg
Semax
5mg
Lot: VUMN9G3
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 28.1 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.3 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.34 mg (106.8 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-163-75
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/24/2026
Date Tested:02/24/2026
Customer:PEPTOVA
Testing material:Semax
Lot Number:45YRQZ2
BT Sample ID:005000038801141
Labeled Peptide:—
Content/Potency:11mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and red cap
Labeled as:Semax
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Semax
11mg
Semax
11mg
Lot: 45YRQZ2
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 56.3 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.2 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 11 mg | 11.88 mg (108 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-154-29
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/24/2026
Date Tested:02/24/2026
Customer:PEPTOVA
Testing material:Sermorelin
Lot Number:S92V07Y
BT Sample ID:005000038801078
Labeled Peptide:—
Content/Potency:2mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and red cap
Labeled as:Sermorelin
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Sermorelin
2mg
Sermorelin
2mg
Lot: S92V07Y
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 12.3 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.1 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 2 mg | 2.05 mg (102.3 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-155-32
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/22/2025
Date Tested:12/22/2025
Customer:PEPTOVA
Testing material:Sermorelin
Lot Number:XJ7J34K
BT Sample ID:005000038801085
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and teal cap
Labeled as:Sermorelin
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Sermorelin
5mg
Sermorelin
5mg
Lot: XJ7J34K
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 26.7 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.4 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.4 mg (108 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-156-98
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/22/2025
Date Tested:12/22/2025
Customer:PEPTOVA
Testing material:Sermorelin
Lot Number:KND61QD
BT Sample ID:005000038801092
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and teal cap
Labeled as:Sermorelin
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Sermorelin
10mg
Sermorelin
10mg
Lot: KND61QD
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 51.6 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.7 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.98 mg (109.8 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-150-34
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/02/2025
Date Tested:12/02/2025
Customer:PEPTOVA
Testing material:TB500 (Thymosin Beta-4)
Lot Number:5SPW36F
BT Sample ID:005000038801050
Labeled Peptide:—
Content/Potency:2mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and green cap
Labeled as:TB500 (Thymosin Beta-4)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
TB500
2mg
TB500
2mg
Lot: 5SPW36F
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 12.1 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.6 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 2 mg | 2.19 mg (109.5 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-151-31
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/03/2026
Date Tested:02/03/2026
Customer:PEPTOVA
Testing material:TB500 (Thymosin Beta-4)
Lot Number:U1J129J
BT Sample ID:005000038801057
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and orange cap
Labeled as:TB500 (Thymosin Beta-4)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
TB500
5mg
TB500
5mg
Lot: U1J129J
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 28.8 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.3 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.07 mg (101.4 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-152-27
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:01/14/2026
Date Tested:01/14/2026
Customer:PEPTOVA
Testing material:TB500 (Thymosin Beta-4)
Lot Number:UDE143L
BT Sample ID:005000038801064
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and orange cap
Labeled as:TB500 (Thymosin Beta-4)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
TB500
10mg
TB500
10mg
Lot: UDE143L
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 49.8 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.8 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.3 mg (103 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 January 2026
Rev 1.0 January 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-148-83
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/27/2025
Date Tested:11/27/2025
Customer:PEPTOVA
Testing material:Tesamorelin (T-RH)
Lot Number:8X09QZW
BT Sample ID:005000038801036
Labeled Peptide:—
Content/Potency:2mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and orange cap
Labeled as:Tesamorelin (T-RH)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Tesamorelin
2mg
Tesamorelin
2mg
Lot: 8X09QZW
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 13 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.1 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 2 mg | 2.2 mg (110.1 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-149-64
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/18/2025
Date Tested:11/18/2025
Customer:PEPTOVA
Testing material:Tesamorelin (T-RH)
Lot Number:147LF0D
BT Sample ID:005000038801043
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and yellow cap
Labeled as:Tesamorelin (T-RH)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Tesamorelin
10mg
Tesamorelin
10mg
Lot: 147LF0D
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 51 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.0 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.9 mg (109 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-101-11
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/27/2025
Date Tested:11/27/2025
Customer:PEPTOVA
Testing material:Tirzepatide (TZ-329)
Lot Number:NB0BYVN
BT Sample ID:005000038800707
Labeled Peptide:—
Content/Potency:5mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and purple cap
Labeled as:Tirzepatide (TZ-329)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Tirzepatide
5mg
Tirzepatide
5mg
Lot: NB0BYVN
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 27 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.1 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 5 mg | 5.44 mg (108.8 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-102-27
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/18/2026
Date Tested:02/18/2026
Customer:PEPTOVA
Testing material:Tirzepatide (TZ-329)
Lot Number:JD0K0P8
BT Sample ID:005000038800714
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and red cap
Labeled as:Tirzepatide (TZ-329)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Tirzepatide
10mg
Tirzepatide
10mg
Lot: JD0K0P8
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 49.8 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.8 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.58 mg (105.8 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-103-62
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/22/2025
Date Tested:12/22/2025
Customer:PEPTOVA
Testing material:Tirzepatide (TZ-329)
Lot Number:9Q3JX0V
BT Sample ID:005000038800721
Labeled Peptide:—
Content/Potency:15mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and clear cap
Labeled as:Tirzepatide (TZ-329)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Tirzepatide
15mg
Tirzepatide
15mg
Lot: 9Q3JX0V
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 73.3 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.7 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 15 mg | 16.39 mg (109.3 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-104-28
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/27/2025
Date Tested:11/27/2025
Customer:PEPTOVA
Testing material:Tirzepatide (TZ-329)
Lot Number:385A3J3
BT Sample ID:005000038800728
Labeled Peptide:—
Content/Potency:20mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and green cap
Labeled as:Tirzepatide (TZ-329)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Tirzepatide
20mg
Tirzepatide
20mg
Lot: 385A3J3
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 93.4 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.0 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 20 mg | 22.08 mg (110.4 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-105-29
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:01/22/2026
Date Tested:01/22/2026
Customer:PEPTOVA
Testing material:Tirzepatide (TZ-329)
Lot Number:09AKLRY
BT Sample ID:005000038800735
Labeled Peptide:—
Content/Potency:30mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and blue cap
Labeled as:Tirzepatide (TZ-329)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Tirzepatide
30mg
Tirzepatide
30mg
Lot: 09AKLRY
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 133.5 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.1 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 30 mg | 30.48 mg (101.6 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 January 2026
Rev 1.0 January 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-106-30
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:11/12/2025
Date Tested:11/12/2025
Customer:PEPTOVA
Testing material:Tirzepatide (TZ-329)
Lot Number:MA5U1WT
BT Sample ID:005000038800742
Labeled Peptide:—
Content/Potency:40mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and clear cap
Labeled as:Tirzepatide (TZ-329)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Tirzepatide
40mg
Tirzepatide
40mg
Lot: MA5U1WT
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 167.4 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.2 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 40 mg | 42.4 mg (106 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 November 2025
Rev 1.0 November 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2025-107-31
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:12/22/2025
Date Tested:12/22/2025
Customer:PEPTOVA
Testing material:Tirzepatide (TZ-329)
Lot Number:GT0121N
BT Sample ID:005000038800749
Labeled Peptide:—
Content/Potency:50mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and orange cap
Labeled as:Tirzepatide (TZ-329)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Tirzepatide
50mg
Tirzepatide
50mg
Lot: GT0121N
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 188 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.3 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 50 mg | 54.45 mg (108.9 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:57:08-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2025.12.20 17:36:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 December 2025
Rev 1.0 December 2025
Peptova Testing Certificate © 2025 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-108-32
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/24/2026
Date Tested:02/24/2026
Customer:PEPTOVA
Testing material:Tirzepatide (TZ-329)
Lot Number:5SVSK6H
BT Sample ID:005000038800756
Labeled Peptide:—
Content/Potency:60mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and teal cap
Labeled as:Tirzepatide (TZ-329)
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Tirzepatide
60mg
Tirzepatide
60mg
Lot: 5SVSK6H
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 216.3 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.4 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 60 mg | 63.48 mg (105.8 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Andrea
Castro,
AS
Digitally signed by Andrea Castro, AS
DN: O=BioTools Inc, CN=
Andrea Castro, AS, E=
acastro@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:14:33-05'00
Foxit PDF Reader Version: 2024.4
Andrea Castro, AS
Scientist-I
BTLabs
BTLabs
Verna
Zheng
AS
Digitally signed by Verna Zheng
AS
DN: O=BioTools Inc, CN=Verna
Zheng AS, E=vzheng@
bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.01.22 09:31:07-05'00
Foxit PDF Reader Version: 2024.4
Verna Zheng, AS
Scientist-I
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.
BTLabs
Powered by BioTools
Report #:
IF-824-QSA-TR006-2026-147-90
Page:
1 of 2
Title:
Certificate of Analysis (CoA)
Date:02/11/2026
Date Tested:02/11/2026
Customer:PEPTOVA
Testing material:Thymalin
Lot Number:ZEP2Z2B
BT Sample ID:005000038801029
Labeled Peptide:—
Content/Potency:10mg
Storage:R.T.
Packing material:Clear glass vial with white label, silver crimp and teal cap
Labeled as:Thymalin
Manufacturer:N/A
Testing Purpose: FTIR and HPLC analysis for the identification, purity, potency and composition of a peptide product. It does not provide information on particulate matter, microbial contamination or presence of endotoxins.
PEPTOVA
Thymalin
10mg
Thymalin
10mg
Lot: ZEP2Z2B
| Test | Method | Specification | Result |
|---|---|---|---|
| General Appearance | USP <630> | White powder | White powder |
| Mass | USP <41> | As recorded | 49.7 mg |
| FTIR Identification and Composition Analysis | USP <197A> | Sample spectrum should confirm the content of peptide via characteristic bands | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | Specifications: ≥ 98 % | 99.8 % |
| HPLC Potency Assay | USP <621> | Specifications: 95 – 105% of 10 mg | 10.87 mg (108.7 %) |
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
Kimberly
Quinn,
MS
Digitally signed by Kimberly Quinn, MS
DN: O=BioTools Inc, CN=
Kimberly Quinn, MS, E=
kquinn@bttools.us
Reason: I am approving this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:02:44-05'00
Foxit PDF Reader Version: 2024.4
Kimberly Quinn, MS
Lab Manager
BTLabs
BTLabs
Sarah
Mitchell,
BS
Digitally signed by Sarah Mitchell, BS
DN: O=BioTools Inc, CN=
Sarah Mitchell, BS, E=
smitchell@bttools.us
Reason: I am the author of this
document
Location: West Palm Beach, FL
Date: 2026.02.18 11:18:52-05'00
Foxit PDF Reader Version: 2024.4
Sarah Mitchell, BS
Scientist-II
BTLabs
BTLabs
IF-824-QSA-TR006
Rev 1.0 February 2026
Rev 1.0 February 2026
Peptova Testing Certificate © 2026 Peptova Research Compounds. All rights reserved. Unauthorized distribution and modification prohibited.